phrykt

Xencor Inc (XNCR): who owns it and who trades it

As of Nov 16, 2026, XNCR insiders reported 20 open-market sales worth $7.4M and no purchases in the last 12 months, with 4% of the sale value made under pre-set 10b5-1 plans. The largest seller was Richard J Ranieri (Director), with $3.2M. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Xencor

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns XNCR

207 funds and institutions reported XNCR shares worth $1.4B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 18.4%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.18.4%
Primecap Management Co13.7%
Bvf Inc9.6%
Rtw Investments, LP9.1%
Ra Capital Management, L.P.7.1%
State Street Corp6.7%
Vanguard Capital Management LLC4.4%
TCG Crossover Management, LLC3.3%
T. Rowe Price Associates3.2%
Vanguard Portfolio Management LLC3.0%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.13.65M18.41%$220M+5%
Primecap Management Co10.18M13.73%$164M-2%
Bvf Inc7.13M9.62%$115MNo change
Rtw Investments, LP6.78M9.14%$109MNo change
Ra Capital Management, L.P.5.27M7.11%$84.9M+8%
State Street Corp4.95M6.68%$79.8M+14%
Vanguard Capital Management LLC3.28M4.42%$52.8M+6%
TCG Crossover Management, LLC2.45M3.31%$39.5MNo change
T. Rowe Price Associates2.36M3.18%$37.9M+51%
Vanguard Portfolio Management LLC2.22M2.99%$35.7M-37%
Geode Capital Management, LLC1.92M2.59%$30.9M+6%
Morgan Stanley1.75M2.36%$28.2M+12%
UBS Group AG1.31M1.76%$21M+21%
Baker Bros. Advisors LP1.10M1.49%$17.7MNo change
Legal & General Group Plc1.09M1.47%$17.6M+2%
Dimensional Fund Advisors LP1.01M1.36%$16.3M-22%
Goldman Sachs Group Inc968,7781.31%$15.6M+27%
Millennium Management LLC853,6771.15%$13.7M+40%
Two Sigma Investments, LP819,5151.11%$13.2M+2%
Northern Trust Corp794,2791.07%$12.8M+7%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, XNCR insiders reported $0 of open-market purchases and $7.4M of sales. 4% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$7.4M
20 trades, 9 people
Sales under a 10b5-1 plan
4%
Share of sale value
Latest trade
Nov 11, 2026
Filed Nov 12, 2026

Purchases and sales by month

$3.6M$3.6MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 11, 2026Bart Jan CornelissenCFOSale10,100$39.82$402KForm 4
Nov 10, 2026Richard J RanieriDirectorSale70,080$39.20$2.7MForm 4
Nov 10, 2026Richard J RanieriDirectorSale11,172$39.59$442KForm 4
Jun 18, 2026Ellen FeigalDirectorSale plan6,843$13.06$89.4KForm 4
Jun 15, 2026Kevin Charles GormanDirectorSale plan7,527$12.31$92.7KForm 4
Jun 15, 2026Kurt A GustafsonDirectorSale plan5,474$12.31$67.4KForm 4
Jun 15, 2026Alan Bruce MontgomeryDirectorSale plan5,064$12.31$62.3KForm 4
Apr 10, 2026Bart Jan CornelissenCFOSale3,499$12.29$43KForm 4
Mar 6, 2026John R DesjarlaisVice presidentSale2,502$11.02$27.6KForm 4
Mar 6, 2026Celia EckertVice presidentSale1,767$11.02$19.5KForm 4
Mar 6, 2026Bassil I DahiyatCEOSale6,606$11.02$72.8KForm 4
Mar 5, 2026John R DesjarlaisVice presidentSale4,118$11.25$46.3KForm 4
Mar 5, 2026Celia EckertVice presidentSale3,244$11.25$36.5KForm 4
Mar 5, 2026Bart Jan CornelissenCFOSale2,517$11.25$28.3KForm 4
Mar 5, 2026Bassil I DahiyatCEOSale14,870$11.25$167KForm 4
Mar 3, 2026John R DesjarlaisVice presidentSale2,663$11.90$31.7KForm 4
Mar 3, 2026Celia EckertVice presidentSale1,492$11.90$17.8KForm 4
Mar 3, 2026Bassil I DahiyatCEOSale6,758$11.90$80.4KForm 4
Dec 19, 2025John R DesjarlaisVice presidentSale73,367$15.72$1.2MForm 4
Dec 19, 2025Bassil I DahiyatCEOSale114,377$15.71$1.8MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Richard J RanieriDirector–$3.2MNov 10, 2026
Bassil I DahiyatPRESIDENT & CEO, Director–$2.1MMar 6, 2026
John R DesjarlaisSR. VICE PRESIDENT & CSO–$1.3MMar 6, 2026
Bart Jan CornelissenSR. VICE PRESIDENT & CFO–$474KNov 11, 2026
Kevin Charles GormanDirector–$92.7KJun 15, 2026
Ellen FeigalDirector–$89.4KJun 18, 2026
Celia EckertSVP, GENERAL COUNSEL–$73.7KMar 6, 2026
Kurt A GustafsonDirector–$67.4KJun 15, 2026
Alan Bruce MontgomeryDirector–$62.3KJun 15, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

XNCR short interest

High short interest. 17.2% of XNCR shares are sold short: about 1 share in 6. Over the last 12 reports the number of shares short went up 20%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 12.90M XNCR shares were sold short, 17.2% of the shares outstanding, up 5.1% from the report before. At the average daily volume of 1.96M shares, buying them all back would take about 6.6 trading days (days to cover).

Shares short, % of all shares

17.2%May 15Oct 3023.2%

Days to cover

6.6May 15Oct 3018.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202612.90M17.19%+5%1.96M6.6
Oct 15, 202612.27M16.50%-25%1.34M9.1
Sep 30, 202616.37M22.01%+4%1.62M10.1
Sep 15, 202615.75M21.18%+6%1.19M13.2
Aug 31, 202614.91M20.06%+5%1.56M9.5
Aug 14, 202614.19M19.08%+25%1.01M14.1
Jul 31, 202611.34M15.26%+5%1.28M8.8
Jul 15, 202610.84M14.62%-6%795,35913.6
Jun 30, 202611.51M15.52%+2%1.19M9.7
Jun 15, 202611.26M15.18%+3%697,08716.1
May 29, 202610.90M14.70%+2%633,10217.2
May 15, 202610.71M14.45%+2%831,28812.9

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Xencor company events

Xencor filed 12 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026ResultsReleased financial results. Filing
  2. Oct 26, 2026AnnouncementThe Company issued a press release announcing updated results from the Phase 1 study of XmAb819, an ENPP3 x CD3 T-cell engaging bispecific antibody, in patients with advanced clear cell renal cell carcinoma. Filing
  3. Aug 5, 2026ResultsReleased financial results. Filing
  4. Jul 29, 2026AgreementXencor, Inc. entered into a settlement agreement and release, with Alexion Pharma International Operations Limited, an Irish limited company with respect to a commercial dispute related to U.S. royalties on Ultomiris® (ravulizumab-cwvz). Filing
  5. Jun 18, 2026VoteReported shareholder vote results. Filing
  6. May 6, 2026ResultsReleased financial results. Filing
  7. May 5, 2026AnnouncementShared information with investors. Filing
  8. Apr 27, 2026LeadershipXencor, Inc. adopted the Xencor, Inc. Executive Severance Policy, pursuant to which certain executives of the Company, including the Company’s currently serving named executive officers with the exception of the Company’s Chief Executive Officer (our “ NEOs ”), are eligible to receive certain… Filing
  9. Mar 9, 2026AgreementEnded an important agreement. Filing
  10. Mar 4, 2026AnnouncementShared information with investors. Filing
  11. Feb 25, 2026ResultsReleased financial results. Filing
  12. Jan 8, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Xencor financials

Famous investors that hold XNCR

5 of the 50 well-known investors we track reported holding XNCR in their latest 13F filing. The largest position is Israel Englander's, worth $18.3M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 2026733,815$18.3M0.0%-14%
Steve Cohen · Point72 Asset ManagementQ3 2026240,673$6M0.0%+236%
Ken Griffin · Citadel AdvisorsQ3 202640,757$1M0.0%-79%
Paul Tudor Jones · Tudor Investment CorpQ3 202639,880$995K0.0%-45%
Jim Simons · Renaissance TechnologiesQ3 202621,800$544K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 10 filings named XNCR in the last 120 days.

FiledHolderFormStake
Nov 16, 2026BIOTECHNOLOGY VALUE FUND L P13G/A4.4%
Nov 16, 2026BIOTECHNOLOGY VALUE FUND L P13G/A4.4%
Nov 13, 2026The Toronto-Dominion Bank13G5.2%
Nov 13, 2026The Toronto-Dominion Bank13G5.2%
Nov 6, 2026PRIMECAP MANAGEMENT CO/CA/13G/A13.3%
Nov 6, 2026PRIMECAP MANAGEMENT CO/CA/13G/A13.3%
Oct 30, 2026Vanguard Capital Management13G/A5.0%
Oct 30, 2026Vanguard Capital Management13G/A5.0%
Oct 27, 2026BlackRock, Inc.13G/A14.5%
Oct 27, 2026BlackRock, Inc.13G/A14.5%

Questions about Xencor Inc (XNCR) stock

Who owns the most XNCR stock?

The largest reported owner of Xencor Inc (XNCR) is BlackRock, Inc., with 18.4% of the company. In total, 207 funds and institutions reported holding XNCR at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are XNCR insiders buying or selling?

In the last 12 months, XNCR insiders reported no open-market purchases and 20 sales worth $7.4M. The latest trade was on Nov 11, 2026. See every trade.

What is the short interest in XNCR?

As of Oct 30, 2026, 12.90M XNCR shares were sold short, 17.2% of the shares outstanding, up 5.1% from the report before. At the average daily volume of 1.96M shares, buying them all back would take about 6.6 trading days (days to cover). See the history.

Which famous investors hold XNCR?

5 of the 50 well-known investors we track reported XNCR in their latest 13F filing, including Israel Englander, Steve Cohen, Ken Griffin. The largest position is worth $18.3M. See all holders.

Executive pay

Xencor's chief executive was paid a total of $5.5M for the year ended Dec 31, 2025, down 19% from $6.8M the year before. In the last 12 months, Xencor's executives and directors bought no stock on the open market and sold $7.4M.

Chief executive, total pay$5.5MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$1.5MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$1.4MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.